You just read:

Takeda and Lundbeck Receive Complete Response Letter for Brintellix® (vortioxetine) sNDA

News provided by

Takeda Pharmaceutical Company Limited , H. Lundbeck A/S

Mar 28, 2016, 20:02 ET